Ultra-rare B decays

被引:0
|
作者
Grinstein, B [1 ]
机构
[1] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA
来源
关键词
D O I
暂无
中图分类号
O412 [相对论、场论]; O572.2 [粒子物理学];
学科分类号
摘要
A good place to look for deviations from the Standard Model is in decay modes of B mesons, like purely leptonic decays B --> lnu, for which a very long Standard Model lifetime is due to an accidental suppression of the decay amplitude. For other rare decay modes involving no hadrons in the final state (e.g., B --> gammal(+)l(-), B --> gammalnu(l), and B --> nunugamma) new results on QCD factorization in exclusive processes show that all the decay rates are given in terms of a single universal form factor. Hence, trustworthy relations between different processes can be used to test the Standard Model of electroweak interactions. Sometimes, surprisingly, a large energy expansion may allow computation when a hadron is in the final state. An example is B --> pil(+)l(-) which can be used to settle the ambiguity in a from a measurement of sin2alpha from CP asymmetries.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 50 条
  • [31] Drug reduces excess iron in ultra-rare neurodegenerative disease
    Sarah Lemprière
    Nature Reviews Neurology, 2019, 15 : 492 - 493
  • [32] Spending on and beneficiaries of orphan cancer drugs for ultra-rare, rare, and common diseases
    Michaeli, J. C.
    Michaeli, C. T.
    Michaeli, D. T.
    ANNALS OF ONCOLOGY, 2023, 34 : S927 - S928
  • [33] Issues in genetic testing for ultra-rare diseases: background and introduction
    Ledbetter, David H.
    Faucett, W. Andrew
    GENETICS IN MEDICINE, 2008, 10 (05) : 309 - 313
  • [34] Relocation of study participants for rare and ultra-rare disease trials: Ethics and operations
    Gelinas, Luke
    Crawford, Brian
    Kelman, Ariella
    Bierer, Barbara E.
    CONTEMPORARY CLINICAL TRIALS, 2019, 84
  • [35] Quantifying the Impact of Rare and Ultra-rare Coding Variation across the Phenotypic Spectrum
    Ganna, Andrea
    Satterstrom, F. Kyle
    Zekavat, Seyedeh M.
    Das, Indraniel
    Kurki, Mitja, I
    Churchhouse, Claire
    Alfoldi, Jessica
    Martin, Alicia R.
    Havulinna, Aki S.
    Byrnes, Andrea
    Thompson, Wesley K.
    Nielsen, Philip R.
    Karczewski, Konrad J.
    Saarentaus, Elmo
    Rivas, Manuel A.
    Gupta, Namrata
    Pietilainen, Olli
    Emdin, Connor A.
    Lescai, Francesco
    Bybjerg-Grauholm, Jonas
    Flannick, Jason
    Mercader, Josep M.
    Udler, Miriam
    Laakso, Markku
    Salomaa, Veikko
    Hultman, Christina
    Ripatti, Samuli
    Hamalainen, Eija
    Moilanen, Jukka S.
    Korkko, Jarmo
    Kuismin, Outi
    Nordentoft, Merete
    Hougaard, David M.
    Mors, Ole
    Werge, Thomas
    Mortensen, Preben Bo
    MacArthur, Daniel
    Daly, Mark J.
    Sullivan, Patrick F.
    Locke, Adam E.
    Palotie, Aarno
    Borglum, Anders D.
    Kathiresan, Sekar
    Neale, Benjamin M.
    AMERICAN JOURNAL OF HUMAN GENETICS, 2018, 102 (06) : 1204 - 1211
  • [36] Drug reduces excess iron in ultra-rare neurodegenerative disease
    Lempriere, Sarah
    NATURE REVIEWS NEUROLOGY, 2019, 15 (09) : 492 - 493
  • [37] Primary mitral valve angiosarcoma: A multifaced ultra-rare tumor
    Akiash, Nehzat
    Mombeini, Hoda
    Gholizadeh, Behnam
    Jazayeri, S. Nematollah
    Azizidoost, Shirin
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2021, 38 (12): : 2100 - 2103
  • [38] INTERVENTIONS FOR ULTRA-RARE DISORDERS (URDS) AND THE LOGIC OF COST EFFECTIVENESS
    Schlander, M.
    Garattini, S.
    Holm, S.
    Kolominsky-Rabas, P.
    Marshall, D. A.
    Nord, E.
    Persson, U.
    Postma, M.
    Richardson, J.
    Simoens, S.
    de Sola-Morales, O.
    Tolley, K.
    Toumi, M.
    VALUE IN HEALTH, 2015, 18 (03) : A6 - A6
  • [39] Beyond Burden Testing - Association Analysis of Ultra-Rare Variants
    Waring, Adam
    Farrall, Martin
    HUMAN HEREDITY, 2017, 83 (01) : 27 - 27
  • [40] Zebrafish models ultra-rare X-linked disease
    Linda Koch
    Nature Reviews Genetics, 2014, 15 (12) : 778 - 778